FDA asks drugmaker to stop selling its opioid painkiller

FDA asks drugmaker to stop selling its opioid painkiller


The Food and Drug Administration said Thursday it has asked Endo Pharmaceuticals to stop selling its reformulated, extended-release painkiller, Opana ER. Endo had touted the new formulation as abuse-resistant, though the FDA did not allow the company to market it as such when granting approval for sales several years ago.



from Biotech News